|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
ot1 From the Department of Clinical, Morphological and Technological Sciences, Division of Internal Medicine, and the Department of Mathematics and Informatics (LT), University of Trieste, Trieste, Italy (GB, FA, MS, and GG); the Institute for Kinesiology Research, University of Primorska, Koper, Slovenia (BS and RP); the Centre for Oxygen, Research and Development, University of Liege, Liege, Belgium (JCP and GD-D); the Division of Endocrinology, University of Milan, Milan, Italy (PM); the Division of Endocrinology and Metabolism, INRCA, Rome, Italy (FS); the Section of Physiology, Department of Biomedical Sciences and Microgravity, Ageing, Training, and Immobility (MATI), University of Udine, Udine, Italy (PdP); the Department of Automation, Biocybernetics and Robotics, Institute Jozef Stefan, Ljubljana, Slovenia (IBM); and the Institute for Biophysical and Clinical Research into Human Movement, Manchester Metropolitan University, Manchester, United Kingdom (MVN). RP and MVN contributed equally to the study and the manuscript
2 Supported by grants from the Italian Space Agency, the Slovenian Minister of Defence, and the Regione Friuli Venezia Giulia. 3 Reprints not available. Address correspondence to G Biolo, Clinica Medica, Ospedale di Cattinara, Strada di Fiume, 447, 34100 Tieste, Italy. E-mail: biolo{at}units.it.
| ABSTRACT |
|---|
|
|
|---|
Objective: We aimed to assess whether energy intake in excess of requirement activates systemic inflammation and antioxidant defenses and accelerates muscle atrophy induced by inactivity.
Design: Nineteen healthy male volunteers were studied before and at the end of 5 wk of bed rest. Subjects were allowed to spontaneously adapt to decreased energy requirement (study A, n = 10) or were provided with an activity-matched diet (study B, n = 9). Groups with higher (HEB) or lower (LEB) energy balance were identified according to median values of inactivity-induced changes in fat mass (
FM, assessed by bioelectrical impedance analysis).
Results: In pooled subjects (n = 19; median
FM: 1.4 kg), bed rest–mediated decreases in fat-free mass (bioelectrical impedance analysis) and vastus lateralis thickness (ultrasound imaging) were significantly greater (P < 0.03) in HEBAB (–3.8 ± 0.4 kg and –0.32 ± 0.04 cm, respectively) than in LEBAB (–2.3 ± 0.5 kg and –0.09 ± 0.04 cm, respectively) subjects. In study A (median
FM: 1.8 kg), bed rest–mediated increases in plasma leptin, C-reactive protein, and myeloperoxidase were greater (P < 0.04) in HEBA than in LEBA subjects. Bed rest–mediated changes of glutathione synthesis rate in eythrocytes (L-[3,3-2H2]cysteine incorporation) were greater (P = 0.03) in HEBA (from 70 ± 19 to 164 ± 29%/d) than in LEBA (from 103 ± 23 to 84 ± 27%/d) subjects.
Conclusions: Positive energy balance during inactivity is associated with greater muscle atrophy and with activation of systemic inflammation and of antioxidant defenses. Optimizing caloric intake may be a useful strategy for mitigating muscle loss during period of chronic inactivity.
| INTRODUCTION |
|---|
|
|
|---|
Overfeeding and excess body fat increase leptin secretion and are associated with low-grade inflammatory response and greater oxidative stress (15, 16). Proinflammatory mediators and redox unbalance potentially play a causative role in lowering muscle protein synthesis and in accelerating proteolysis (17, 18). Overfeeding led to a significant reduction in the protein fractional synthesis rate (FSR) in muscle of rats (19). Systemic inflammation upregulates cellular antioxidant defenses, including the thiol (functional group composed of a sulfur atom and a hydrogen atom; -SH) tripeptide (L-
-glutamyl-L-cysteinylglycine) glutathione (20), which is highly concentrated in erythrocytes and which provides local and systemic antioxidant protection (21).
The current study was conducted to test the hypothesis that positive energy balance (ie, EI in excess of requirements) leading to fat deposition could accelerate inactivity-induced loss of lean mass and could activate systemic inflammation, free radical production, and antioxidant defenses. Energy balance was determined from the overall 35-d change in body fat mass, as determined by bioelectrical impedance analysis [BIA (22)], and from changes in leptin concentration (23). Evaluation of antioxidant defenses included determination of erythrocyte glutathione turnover by the incorporation of stable isotope (24).
| SUBJECTS AND METHODS |
|---|
|
|
|---|
± SEM age: 24 ± 1 y; body mass index (in kg/m2): 23.5 ± 0.6] were selected to investigate the effects of experimental bed rest at different EIs. Ten subjects were studied in July and August 2006 (study A), and 9 subjects were studied in July and August 2007 (study B). All subjects were physically active before admission to the Valdoltra Hospital, University of Primorska (Ankaran-Capodistria, Slovenia). Their body mass was stable for
3 mo before the studies.
Routine medical and laboratory analyses were performed to exclude chronic diseases. None of the subjects were regularly taking any medication. The experiments were part of comprehensive, international collaborative bed-rest studies. The bed-rest periods were preceded by a 1-wk ambulatory adaptation period, in which each subject received a weight-maintaining diet containing 1.4 times his resting energy expenditure, calculated by using the FAO/WHO equations (25). The diet contained
60% of energy as carbohydrate, 25% as fat, and 15% as protein. Six meals were administered daily: 3 main meals (breakfast, lunch, and dinner) and 3 snacks. During the 35-d bed-rest period of study A, a diet with the same energy, frequency, and relative macronutrient content of that planned in the ambulatory adaptation period was offered to subjects. Subjects were not required to consume all served food, but they were allowed to adapt spontaneously to decreased energy requirements during inactivity. Leftover food was monitored semiquantitatively by an expert dietitian to assess the relative macronutrient intake. During the 35-d bed-rest period of study B, each subject received an activity-adjusted diet containing 1.2 times his resting energy expenditure (25) and with the same meal frequency and relative macronutrient content of that planned in study A. Subjects were required to consume all food served.
The body composition of all subjects was measured by using BIA [Human IM Plus; DS Dietosystem, Milan, Italy (22)] at the end of both the ambulatory adaptation period and the bed-rest period of both studies. During studies A and B, the thickness of the vastus lateralis muscle was measured while the subject was in the supine position, by using ultrasound imaging on a portable ultrasound device (MyLab25; ESAOTE, Genoa, Italy) fitted with a 10–15-MHz linear probe (26). Sagittal ultrasound images were obtained at 50% of muscle length measured along the mid-sagittal axis, after identification of the proximal and medial bone insertions of muscle. Muscle thickness was measured, and expressed in cm, as the vertical distance between muscle superficial and deep aponeuroses at an equidistant point from the right and left borders of the image. Only in study A, in addition to the thickness of the vastus lateralis, the thicknesses of the gastrocnemius medialis, tibialis anterior, and biceps brachii muscles were measured. Then, a mean value of the thickness of representative postural and nonpostural muscles was calculated.
Markers of inflammatory response and erythrocyte glutathione turnover rates were determined during the postabsorptive state at the end of both the ambulatory adaptation and the bed-rest periods in study A. After background blood sampling, a primed continuous infusion of L-[3,3-2H2]cysteine (Cambridge Isotope Laboratories, Andover, MA) (priming dose: 150 µmol; continuous infusion rate: 150 µmol/h) was started at 0700 or 0800 and continued for 5 h. A total of 10 mL arterialized venous blood was obtained at times 3, 4, and 5 h to measure hematocrit and the concentration and 2H2 enrichment of erythrocyte-free cysteine and glutathione (24). Whole blood was immediately centrifuged, and plasma and leukocytes were removed and replaced with an equal volume of cold distilled water. Both plasma and erythrocyte solutions were frozen at –80 °C for later analysis. Plasma and erythrocyte concentrations of glutathione and of glutathione amino acid precursors were measured in the background sample. At time 5 h, selected plasma hormone, mediator, and metabolite concentrations were measured in plasma, and glutathione peroxidase activity and protein concentrations in the catalytic and modulatory subunits of glutamate cysteine ligase were measured in erythrocytes. At 1200 or 1300, isotope infusion was discontinued.
All volunteers provided written informed consent. The experimental protocols were approved by the Ethics Committee of the University of Ljubljana (Ljubljana, Slovenia), and they conformed to the standards set by the Declaration of Helsinki (2002).
Analyses
The procedure for analysis of erythrocyte glutathione and cysteine isotopic enrichments was adapted from Lyons et al (24). Erythrocyte suspension obtained from 400 µL whole blood was placed into already-chilled tubes containing 1 mL ice-cold dithiothreitol (20 mmol/L in 1 mol acetic acid/L). Proteins were precipitated with 400 µL sulfosalicylic acid 30% and centrifuged for 15 min at 10 000 x g at 4 °C. The supernatant fluid was transferred to a column containing 2 mL of a cation-exchange resin (AG 50W-X8; Bio-Rad, Hercules, CA). After washing with Milli-Q water [5 mL x 2; Millipore, Bedford, MA), glutathione was eluted from the column by using NH4OH (3 mol/L) and collected into derivatization tubes (10 mL). Ammonia was eliminated under gentle nitrogen flow at room temperature. Samples were frozen, lyophilized, and reacted with 500 µL dithiothreitol solution (20 mmol/L in 0.5 mol acetic acid/L) at 100 °C for 1 h to reduce any dimerized glutathione and then dried again in nitrogen flow. Each sample was reacted with 300 µL HCl/methanol solution (250 µL 36% HCl in 7.5 mL methanol), incubated for 30 min at 80 °C, and dried in nitrogen flow at 65 °C before being further reacted with 50 µL N-methyl-N-tert-butyl-dimethysilyl-trifluoroacetamide and 50 µL acetonitrile for 40 min at 90 °C before injection into a gas chromatograph–mass spectrometer [(GC-MS) HP 5890; Agilent Technologies, Santa Clara, CA]. The GC-MS analyses of glutathione and cysteine were carried out by using a fixed silica capillary column (HP-5MS; Agilent Technologies: 25-mm internal diameter and 0.25-µm film thickness). Column temperature was programmed to rise by 10 °C/min from 160 to 300 °C (detector temperatures were 260 °C) with the use of helium as the carrier gas. The derivative was measured under electron-impact ionization by selective ion monitoring at a nominal mass-to-charge ratio (m/z) of 363/365 for glutathione enrichment and of 406/408 for cysteine enrichment.
Total glutathione concentrations in plasma and erythrocytes obtained from background samples were measured by using GC-MS and the internal standard technique. Briefly, known amounts of [glycine-13C215N]glutathione (Cambridge Isotope Laboratories, Andover, MA) were added as internal standard to erythrocyte suspension obtained from 400 µL whole blood and to 200 µL plasma. Samples were processed as described above. The derivative was measured under electron-impact ionization by selective ion monitoring at a nominal m/z of 363/366. Plasma and erythrocyte concentrations of glutathione precursor amino acids (glycine, glutamine, glutamate, methionine, homocysteine, and cysteine in plasma; glycine, glutamine, glutamate, methionine, and cysteine in erythrocytes) were measured in background samples by using GC-MS and the internal standard technique according to Valerio et al (27). Briefly, known amounts of L-[15N]glicine, L-[15N]glutamate, L-[15N]glutamine, DL-[3,3,3',3',4,4,4',4'-2H8]-homocysteine, L-[1-13C, methyl-2H3] methionine, and L-[3,3-2H2]cysteine (Cambridge Isotope Laboratories) were added as internal standards to an erythrocyte suspension obtained from 400 µL whole blood and to 200 µL plasma. Samples were processed as described (27). The derivative was measured under electron-impact ionization by selective ion monitoring at a nominal m/z of 218/219 for glycine, 432/433 for glutamate, 431/432 for glutamine, 496/500 for homocysteine, 320/324 for methionine, and 406/408 for cysteine.
Plasma leptin concentrations were measured by using an enzyme-linked immunosorbent assay (human Leptin Quantikine kit, catalog #DLP00; R&D Systems, Minneapolis, MN). Plasma C-reactive protein (CRP) concentrations were measured by using a high-sensitivity enzyme-linked immunosorbent assay kit (Diagnostics Biochem, London, Canada). Plasma insulin concentrations were measured by using a radioimmunoassay (Adaltis insulin kit; Adaltis Inc, Montreal, Canada). Total plasma ghrelin concentrations were measured by using a radioimmunoassay (Total Human Ghrelin, GHRT-89HK; Linco, St Charles, MO). Plasma glucose, total cholesterol, HDL-cholesterol, and triglyceride concentrations were measured by using commercially available kits (Olympus System Reagents; Olympus Diagnostica GmbH, Hamburg, Germany) by using an autoanalyzer (Olympus AU400 System; Olympus, Tokyo, Japan). LDL cholesterol was calculated by using the Friedewald equation: LDL cholesterol = total cholesterol –HDL cholesterol –(triglycerides x 5) (28).
With antibodies obtained from rabbits and guinea pigs, neutrophil myeloperoxidase plasma concentrations were measured with the use of an enzyme-linked immunosorbent assay (29). Serum immunoglobulin G was isolated by affinity chromatography after immunization with purified human neutrophil myeloperoxidase. A reference curve was performed with purified human myeloperoxidase. Total –SH (thiol) functions (free –SH or bound to proteins) were measured in plasma by using spectrophotometry (at 412 nm) after the reaction of –SH with 5,5' dithiobis-2-nitrobenzoic acid (30). A reference curve was performed with reduced glutathione. Total –SH values were expressed as mol/g protein. Total proteins were measured by using the Bio-Rad Protein Assay reagent and expressed in mg/mL. Glutathione peroxidase activity was determined in erythrocytes according to Paglia and Valentine (31) and expressed as µmol metabolized NADPH · min–1 · g protein–1 in the presence of an organic hydroperoxide (cumolhydroperoxide) and of reduced glutathione as enzyme cofactor (31).
Catalytic and modulator subunit expression of glutamate-cysteine ligase in erythrocytes was measured by Western blot analysis (32). Briefly, proteins were extracted from red blood cells by using a lysis buffer (45 mmol/L Tris-HCl, 0.2% N-laurylsarcosine; Sigma-Aldrich, St Louis, MO) containing proteinase and phosphatase inhibitors (0.2 mmol phenylmethanesulfonyl fluoride/L, 1 mmol dithiothreitol/L, 2 µg aprotinin/mL, 2 µg pepstatin/mL, 0.1 mmol NaF/mL, and 0.1 mmol Na3VO4/L; all: Sigma-Aldrich). After centrifugation (10 min, RT, 16 00 x g), proteins were separated by sodium dodecyl sulfate–polacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Protran; Perkin Elmer, Boston, MA). Proteins were recognized by using commercial antibodies raised against the catalytic (GCLc: sc-22755) and modulator (GCLm: sc-22754) (both: Santa Cruz Biotechnology Inc, Santa Cruz, CA) subunits of the glutamate-cysteine ligase. Glyceraldehyde-3-phosphate dehydrogenase was recognized by commercial antibody (sc-25778; Santa Cruz Biotechnology Inc). A goat anti-rabbit horseradish peroxidase–conjugated immunoglobulin G (Sigma-Aldrich) was used as secondary antibody. Protein complexes were detected by enhanced chemiluminescence (Amersham Life Sciences, Arlington Heights, IL) on photographic film (Kodak Biomax Light Film; Sigma-Aldrich). Protein concentrations in the catalytic and modulator subunits of glutamate-cysteine ligase were measured by band densitometry as a ratio with glyceraldehyde-3-phosphate dehydrogenase protein concentration (Model 45–700 Imaging Densitometer; Bio-Rad).
Calculations
Isotopic enrichments were expressed as tracer-to-tracee ratio (TTR). Erythrocyte cysteine concentrations were measured in separate background samples by dividing internal standard concentration by internal standard enrichment and then normalizing by the erythrocyte volume obtained from hematocrit. Erythrocyte glutathione concentrations were measured in separate background samples by using a standard calibration curve in which fixed amounts of internal standard were added to variable known glutathione concentrations. Values of glutathione concentrations were normalized by erythrocyte volume (µmol/L) obtained from hematocrit. Glutathione fractional synthesis rate (FSR; in %/d) was calculated as {[E(2H2glutathione)/t]/E(2H2cysteine)} x 24 x 100, where E(2H2glutathione)/t is the slope (TTR/h) of the regression line describing the rise in erythrocyte 2H2-glutathione enrichment (TTR) as a function of time (hours) over the last 2 h of isotope infusion, and E(2H2cysteine) is the mean steady-state 2H2-cysteine enrichment (TTR) in erythrocytes over the last 2 h of isotope infusion. Glutathione absolute synthesis rate (µmol · L–1 · d–1) was calculated by multiplying glutathione FSR by erythrocyte glutathione concentration.
Statistical analysis
All data were presented as means ± SEMs. Baseline data on body weight, fat mass, fat-free mass, and vastus lateralis thickness of subjects from study A (n = 10) and study B (n = 9) were compared by unpaired t test. There were no significant differences in baseline data of subjects from study A and study B. Results of subjects from studies A and B, evaluated in ambulatory and bed-rest conditions, were analyzed with a repeated-measures analysis of variance (ANOVA), with activity (ambulatory and bed rest) as within-subject factor and group (studies A and B) as between-subject factor. There was no significant group (study A or study B) x bed rest interaction for investigated variables.
To investigate the influence of energy balance on fat-free mass and muscle atrophy progression during 35 d of bed rest, pooled subjects from studies A and B (n = 19) were divided in 2 groups by using the median value of individual changes in fat mass as threshold. The 10 subjects with fat mass gain greater than the median value were assigned to a group defined as having a higher energy balance (HEBAB; subscript letters indicate the study from which subjects were taken, with "AB" indicating that subjects were taken from both studies). Conversely, the 9 subjects with fat mass changes lower than the median value were assigned to a group defined as having a lower energy balance (LEBAB). There were no significant differences (unpaired t test) in baseline data (ie, body weight, fat mass, fat-free mass, and vastus lateralis thickness) in subjects from the HEBAB and LEBAB groups. Results from the 2 groups, studied in ambulatory and bed-rest conditions, were analyzed with a repeated-measures ANOVA, with activity (ambulatory and bed rest) as within-subject factor and group (higher and lower energy balance) as between-subject factor. Post hoc analysis was performed, when appropriate (ie, significant bed-rest effect and group x bed rest interaction), by t test with Bonferroni's adjustment to assess the effects of bed rest in either group.
To investigate the influence of energy balance on bed rest–mediated changes in inflammatory markers and erythrocyte glutathione turnover, subjects from study A (n = 10) were divided in 2 groups by using the median value of individual changes in fat mass as threshold. Values of hormones, mediators, and substrates concentrations were included in the analysis after log transformation. Baseline data on subjects from higher (HEBA; n = 5) or lower (LEBA; n = 5) energy-balance groups were compared by using an unpaired t test. Results from the 2 groups, studied in ambulatory and bed-rest conditions, were analyzed by using a repeated-measures ANOVA, with activity (ambulatory or bed rest) as within-subject factor and group (higher or lower energy balance) as between-subject factor. Post hoc analysis was performed, when appropriate (ie, significant bed-rest effect and group x bed rest interaction), by t test with Bonferroni's adjustment to assess the effects of bed rest in either group. All comparisons were considered significant at the conventional P < 0.05. The relations between variables were analyzed by bivariate correlation using the Pearson's coefficient. Statistical analysis was conducted with SPSS statistical software (version 12; SPSS Inc, Chicago, IL).
| RESULTS |
|---|
|
|
|---|
To investigate the influence of energy balance on fat-free mass and muscle atrophy progression during 35 d of bed rest, pooled subjects from studies A and B were divided into 2 groups by using the median value of individual changes in fat mass (ie, 1.4 kg) as threshold. The 10 subjects (7 from study A and 3 from study B) with fat mass gain greater than the median value were assigned to a group defined as higher energy balance (HEBAB). Conversely, the 9 subjects (3 from study A and 6 from study B) with fat mass changes lower than the median value were assigned to a group defined as lower energy balance (LEBAB) (Table 1
). Baseline body weight, fat mass, fat-free mass, and vastus lateralis thickness did not differ significantly between the 2 groups (Table 1
). There were significant bed-rest effects and group x bed rest interactions for fat-free mass and vastus lateralis thickness. Bed rest–induced decreases in fat-free mass were greater in HEBAB (3.8 ± 0.4 kg) than in LEBAB (2.3 ± 0.5 kg). Bed rest–induced decreases in thickness of vastus lateralis were greater in HEBAB (0.32 ± 0.04 cm; ie, 14 ± 2%) than in LEBAB (0.09 ± 0.04 cm; ie, 6 ± 5%). There were significant bed-rest effects (P < 0.001) and group x bed rest interactions (P < 0.01) for intracellular water, as determined by multifrequency BIA. Intracellular water decreased in HEBAB from 32.4 ± 1.0 to 30.6 ± 1.0 kg and in LEBAB from 30.6 ± 1.0 to 29.6 ± 0.9 kg. Bed rest–induced decreases in intracellular water were greater in HEBAB (1.9 ± 0.2 kg) than in LEBAB (1.0 ± 0.2 kg).
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
We used 2 independent methods to assess the effects of bed rest at various levels of energy balance on skeletal muscle and fat-free mass. BIA is a validated method for assessing fat mass and fat-free mass in healthy persons; the latter measure is a close marker of whole-body muscle mass (22). Muscle atrophy assessment was directly performed by ultrasonography measurement of muscle thickness. This is a validated technique for assessing muscle size (26, 33). Thickness of the vastus lateralis, a key postural and locomotor muscle, and total-body fat-free mass decreased after bed rest in subjects with greater increases in body fat more than it decreased in those with smaller changes in body fat. The average thickness of representative postural (vastus lateralis, gastrocnemius medialis, and tibialis anterior) and nonpostural (biceps brachii) muscles correlated directly with whole-body fat-free mass, as determined by BIA, both before and at the end of the bed-rest period.
Glutathione plays a major role in cellular defenses against oxidative stress (20). Higher concentrations are present in erythrocytes, providing both local and systemic antioxidant protection (21). Different components of glutathione system in erythrocytes were considered. Glutathione synthetic capacity was assessed by Western blot determination of expression levels of catalytic and modulatory subunits of the glutamate-cysteine ligase enzyme, which catalyzes the rate-limiting step in glutathione biosynthesis (32). The actual rate of glutathione turnover was determined by using a primed continuous infusion of deuterated cysteine and by monitoring incorporation of the labeled precursor into glutathione by MS analysis (24), whereas glutathione function was evaluated through measurement of glutathione peroxidase activity (31). We found group x bed rest interactions for the catalytic subunit of the glutamate-cysteine ligase enzyme and the rate of glutathione turnover leading to greater bed rest–mediated increases in glutathione synthesis in the HEB than in the LEB group. Glutathione peroxidase activity did not change in the 2 groups. Our results indicate that the erythrocyte glutathione system is greatly activated during bed rest at positive energy balance, whereas bed rest at near-neutral balance is not associated with significant changes in glutathione synthesis.
Evidence indicates that glutathione synthesis is up-regulated by proinflammatory mediators and oxidative stress (20). We found significant group x bed rest interactions for plasma CRP and myeloperoxidase concentrations, which led to greater bed rest–mediated increases of these mediators in the HEB group than in the LEB group. Plasma CRP and myeloperoxidase are suitable markers of activation of systemic inflammation (34). These results strongly suggest that an activation of the erythrocyte glutathione system is part of the systemic inflammatory and stress reaction to bed rest at positive energy balance. Inflammatory response and redox unbalance could mediate lean body mass catabolism during bed rest at positive energy balance (17–19). In addition, an increased ghrelin response after a period of overfeeding (35) could contribute to an enhancement of muscle catabolism (36).
One limitation of the present study is that, typically, only a small number of persons can be enrolled in bed-rest studies. The effect of positive energy balance on inactivity-induced muscle atrophy was assessed by combining the results of 2 bed-rest studies, conducted under the same experimental conditions, to achieve a sample size of 19 subjects. In contrast, energy level x bed rest interactions for inflammatory markers and glutathione kinetics were assessed in 2 groups of only 5 subjects. Although extending these observations in a larger population would reinforce the present findings, but we were able to detect significant differences in key markers of inflammatory response and glutathione kinetics.
Positive energy balance (ie, EI in excess of requirements) leads to fat deposition, and changes in body fat mass closely reflect energy balance over the long term, even in the presence of atrophying muscles. In fact, energy density of fat tissue is 9 times that of muscle and fat-free mass (37). Our study A subjects were allowed to spontaneously adapt to decreased energy requirement during bed rest, whereas study B subjects were provided an activity-adjusted diet (1.2 times their calculated resting energy expenditure). At the end of the bed-rest periods, 9 of 10 study A subjects and 5 of 9 study B participants had gained >0.5 kg fat mass. Thus, study A subjects failed to spontaneously adapt to a lower energy requirement, whereas, in study B, an activity-adjusted diet based on traditional predictive equations (22, 38) overestimated the true requirement for most subjects. Achievement of energy balance during experimental bed rest is a difficult task that involves constant monitoring of individual energy requirements and intakes, and that goal has rarely been attained in previous investigations. Results obtained in the present study and in 9 previously reported bed-rest studies that found positive mean changes in fat mass (6–14) are shown in Figure 2
. Changes in fat mass are related to changes in lean body mass (by dual-energy X-ray absorptiometry) or fat-free mass (by BIA). A gain of body fat and a loss of lean (fat-free) mass are expressed as weekly percentage changes from baseline. Linear regression analysis indicates an indirect relation between fat gain and lean (fat-free) mass loss, regardless of the duration of inactivity (Figure 2
). Similar results are obtained by excluding the present study from the analysis (r = –0.97). Thus, there is excellent agreement between the retrospective analysis (6–14; Figure 2
) and the results from the present study, which suggest that, when EI is not strictly controlled during bed rest, fat mass tends to increase in parallel with lean body mass catabolism.
|
| ACKNOWLEDGMENTS |
|---|
The authors' responsibilities were as follows—GB: design of the experiment, collection and analysis of data, and writing of the manuscript; FA: design of the experiment, collection and analysis of data, and writing of the manuscript; BS: design of the experiment and collection of data; MS: collection and analysis of data; LT: design of the experiment and statistical analysis of data; JCP: collection and analysis of data; GD-D: collection and analysis of data; PM, analysis of data; FS: collection and analysis of data; PdP: design of the experiment; GG: design of the experiment; IBM: design of the experiment and collection and analysis of data; MVN: design of the experiment and collection and analysis of data; and RP: design of the experiment, collection and analysis of data, and writing of the manuscript. None of the authors had a personal or financial conflict of interest.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. Dalla Libera, B. Ravara, V. Gobbo, E. Tarricone, M. Vitadello, G. Biolo, G. Vescovo, and L. Gorza A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscle J Appl Physiol, August 1, 2009; 107(2): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |